630
Participants
Start Date
September 12, 2024
Primary Completion Date
March 31, 2029
Study Completion Date
March 31, 2029
LY3962673
Administered orally.
Cetuximab
Administered intravenously.
Gemcitabine
Administered intravenously.
nab-paclitaxel
Administered intravenously.
Oxaliplatin
Administered intravenously.
leucovorin
Administered intravenously.
Irinotecan
Administered intravenously.
5-fluorouracil
Administered intravenously.
RECRUITING
New York University (NYU) Langone Medical Center, New York
RECRUITING
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Charite Universitaetsmedizin Berlin, Berlin
NOT_YET_RECRUITING
Centre d'Essais Precoces en Cancerologie de Marseille (CEPCM) - AP-HM Hopital de La Timone, Marseille
RECRUITING
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh
RECRUITING
Sibley Memorial Hospital, Washington D.C.
RECRUITING
Duke University Medical Center, Durham
RECRUITING
South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Emory University School of Medicine, Atlanta
NOT_YET_RECRUITING
Oncopole Claudius Regaud, Toulouse
RECRUITING
Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
RECRUITING
Centro Ricerche Cliniche di Verona s.r.l., Verona
RECRUITING
Sarah Cannon Research Institute, Nashville
RECRUITING
USO - US Oncology Research Network, Nashville
RECRUITING
Vanderbilt University School of Medicine, Nashville
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Universitaetsklinikum Essen, Essen
RECRUITING
University of Cincinnati (UC) - Cancer Institute, Cincinnati
RECRUITING
Community Health Network, Indianapolis
RECRUITING
Barbara Ann Karmanos Cancer Institute, Detroit
RECRUITING
South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
RECRUITING
University of Wisconsin - Carbone Cancer Center, Madison
NOT_YET_RECRUITING
Centre Leon Berard, Lyon
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
South Texas Accelerated Research Therapeutics (START), San Antonio
RECRUITING
Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Napoli
RECRUITING
Sarah Cannon Research Institute at HealthOne, Denver
RECRUITING
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München
RECRUITING
Huntsman Cancer Institute, Salt Lake City
RECRUITING
University of California, Los Angeles (UCLA), Los Angeles
RECRUITING
City of Hope, Duarte
NOT_YET_RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Fred Hutchinson Cancer Center, Seattle
NOT_YET_RECRUITING
Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing
NOT_YET_RECRUITING
Beijing Cancer hospital, Beijing
NOT_YET_RECRUITING
Harbin Medical University Cancer Hospita, Harbin
NOT_YET_RECRUITING
Fudan University Cancer Center, Shanghai
NOT_YET_RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
The Ottawa Hospital, Ottawa
RECRUITING
Princess Margaret Hospital, Toronto
RECRUITING
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden
RECRUITING
START Dublin Early Phase Clinical Trials Unit, Dublin
RECRUITING
UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma
RECRUITING
National Cancer Center Hospital East, Chiba
RECRUITING
Kanagawa cancer center, Kanagawa
RECRUITING
Aichi Cancer Center Hospital, Nagoya
RECRUITING
Kansai Medical University Hospital, Osaka
RECRUITING
National Cancer Center Hospital, Tokyo
RECRUITING
South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona
RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
Eli Lilly and Company
INDUSTRY